Register Login

INCANNEX HEALTHCARE INC. (IXHL)

SymbolIXHL
NameINCANNEX HEALTHCARE INC.
SectorHEALTH CARE
RegionOceania
IndustryBiotechnology: Pharmaceutical Preparations
AddressRIALTO SOUTH TOWER,LEVEL 23,525 COLLINS STREET, MELBOURNE, 3008, Australia
Telephone+61 409 - 840 786
Fax—
Email—
Websitehttps://www.incannex.com.au
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001873875
Description

Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Additional info from NASDAQ:
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

2026-08-14 22:54

New Form SCHEDULE 13G - Incannex Healthcare Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001326389-26-000065 <b>Size:</b> 7 KB

Read more
2026-08-11 11:30

(85% Positive) INCANNEX HEALTHCARE INC. (IXHL) Reports Q3 2026 Financial Results

Read more
2026-07-23 12:00

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

Read more
2026-07-23 11:30

(90% Positive) INCANNEX HEALTHCARE INC. (IXHL) Announces Clinical Development Update

Read more
2026-06-25 12:00

Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea

Read more
2026-06-25 11:31

(85% Positive) INCANNEX HEALTHCARE INC. (IXHL) Announces Enrollment Update for Treatment Due to Patient Enrollment Issues, Regulatory Process, Efficacy Assessment

Read more
2026-06-09 12:00

Incannex Announces Initiation of Research Coverage by Alliance Global Partners

Read more
2026-06-09 11:30

(95% Neutral) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on medicines for generalized anxiety disorder

Read more
2026-05-14 14:35

Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea

Read more
2026-05-14 11:30

(90% Positive) INCANNEX HEALTHCARE INC. (IXHL) Announces Enrollment Update for partner Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Read more